Syn-flex sales expected to soar with demise of Vioxx

10/08/04  J.R. Rogers

Action Menu With the withdrawal of Vioxx from the market, the makers of Syn-flex predict that sales of their product will rise dramatically. Syn-flex is a powerful, pharmaceutical quality liquid arthritis product that has been an industry leader for years. It also costs a fraction of what prescription drugs like Vioxx cost. “The withdrawal of Vioxx from the market is certainly going to bring Bextra and Celebrex under scrutiny by the manufacturers and government agencies” said J. R. Rogers, president and CEO of Activex America, Inc., the makers of Syn-flex. We have always maintained that the use of Cox-II inhibitors posed risks and this recall seems be bear that conclusion.” Syn-flex, widely used by those who suffer from osteoarthritis is a powerful tool in fighting the pain of osteoarthritis. Through its internet presence, Syn-flex is sold worldwide and has been a huge success with athletes and for pet owners as well. Rogers went on to say, ”Syn-flex is definitely not like store brands of glucosamine. . Many have proved disappointing to consumers. Syn-flex is a liquid and it goes to work fast to get pain under control. In addition to being safe, it is also inexpensive. We have many doctors and veterinarians that recommend our product and we expect that market to also boomerang.” One thing is for certain. This industry leader is in the right place at the right time. J.R. Rogers is the founder and President of Activex America, Inc. makers of Liquid Glucosamine Formula Syn-flex®

The author's statements have not been evaluated by the Food and Drug Administration and are not provided to diagnose any disease or to suggest that liquid glucosamine and chondroitin will treat, cure, or prevent any disease.